<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32449313</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1757-4684</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>08</Day></PubDate></JournalIssue><Title>EMBO molecular medicine</Title><ISOAbbreviation>EMBO Mol Med</ISOAbbreviation></Journal><ArticleTitle>HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies.</ArticleTitle><Pagination><StartPage>e10622</StartPage><MedlinePgn>e10622</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e10622</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/emmm.201910622</ELocationID><Abstract><AbstractText>TAR DNA-binding protein 43 (TDP-43) has been implicated in frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-TDP) and amyotrophic lateral sclerosis. Histone deacetylase 1 (HDAC1) is involved in DNA repair and neuroprotection in numerous neurodegenerative diseases. However, the pathological mechanisms of FTLD-TDP underlying TDP-43 proteinopathies are unclear, and the role of HDAC1 is also poorly understood. Here, we found that aberrant cell cycle activity and DNA damage are important pathogenic factors in FTLD-TDP transgenic (Tg) mice, and we further identified these pathological features in the frontal cortices of patients with FTLD-TDP. TDP-43 proteinopathies contributed to pathogenesis by inducing cytosolic mislocalization of HDAC1 and reducing its activity. Pharmacological recovery of HDAC1 activity in FTLD-TDP Tg mice ameliorated their cognitive and motor impairments, normalized their aberrant cell cycle activity, and attenuated their DNA damage and neuronal loss. Thus, HDAC1 deregulation is involved in the pathogenesis of TDP-43 proteinopathies, and HDAC1 is a potential target for therapeutic interventions in FTLD-TDP.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Published under the terms of the CC BY 4.0 license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Cheng-Chun</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jin</LastName><ForeName>Lee-Way</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, UC Davis Medical Center, Sacramento, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>I-Fang</ForeName><Initials>IF</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei-Yen</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Pei-Chuan</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yu-Chih</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Kuen-Jer</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0002-2170-9735</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NSC-102-2320-B-006-040-MY3</GrantID><Agency>Ministry of Science and Technology, Taiwan (MOST)</Agency><Country>International</Country></Grant><Grant><GrantID>MOST-103-2321-B-006-028</GrantID><Agency>Ministry of Science and Technology, Taiwan (MOST)</Agency><Country>International</Country></Grant><Grant><GrantID>MOST-104-2321-B-006-010</GrantID><Agency>Ministry of Science and Technology, Taiwan (MOST)</Agency><Country>International</Country></Grant><Grant><GrantID>MOST-105-2321-B-006-002</GrantID><Agency>Ministry of Science and Technology, Taiwan (MOST)</Agency><Country>International</Country></Grant><Grant><GrantID>MOST-105-2628-B-006-016-MY3</GrantID><Agency>Ministry of Science and Technology, Taiwan (MOST)</Agency><Country>International</Country></Grant><Grant><GrantID>MOST-106-2628-B-006-001-MY4</GrantID><Agency>Ministry of Science and Technology, Taiwan (MOST)</Agency><Country>International</Country></Grant><Grant><GrantID>P30AG10129</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30AG10129</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO Mol Med</MedlineTA><NlmUniqueID>101487380</NlmUniqueID><ISSNLinking>1757-4676</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.98</RegistryNumber><NameOfSubstance UI="C110550">HDAC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.5.1.98</RegistryNumber><NameOfSubstance UI="D056284">Histone Deacetylase 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056284" MajorTopicYN="N">Histone Deacetylase 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="Y">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">FTLD</Keyword><Keyword MajorTopicYN="N">HDAC1</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32449313</ArticleId><ArticleId IdType="pmc">PMC7278561</ArticleId><ArticleId IdType="doi">10.15252/emmm.201910622</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y et&#xa0;al (2006) TDP&#x2010;43 is a component of ubiquitin&#x2010;positive tau&#x2010;negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Comm 351: 602&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates EA, Victor M, Jones AK, Shi Y, Hart AC (2006) Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. J Neurosci 26: 2830&#x2013;2838</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6675170</ArticleId><ArticleId IdType="pubmed">16525063</ArticleId></ArticleIdList></Reference><Reference><Citation>Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597&#x2013;601</Citation><ArticleIdList><ArticleId IdType="pubmed">9468139</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE (2008) Multiple roles of TDP&#x2010;43 in gene expression, splicing regulation, and human disease. Front Biosci 13: 867&#x2013;878</Citation><ArticleIdList><ArticleId IdType="pubmed">17981595</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerna D, Camphausen K, Tofilon PJ (2006) Histone deacetylation as a target for radiosensitization. Curr Top Dev Biol 73: 173&#x2013;204</Citation><ArticleIdList><ArticleId IdType="pubmed">16782459</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen&#x2010;Plotkin AS, Lee VM, Trojanowski JQ (2010) TAR DNA&#x2010;binding protein 43 in neurodegenerative disease. Nat Rev Neurol 6: 211&#x2013;220</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892118</ArticleId><ArticleId IdType="pubmed">20234357</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA (2013) Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41: 118&#x2013;130</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Lee VM, Trojanowski JQ (2011) TDP&#x2010;43 functions and pathogenic mechanisms implicated in TDP&#x2010;43 proteinopathies. Trends Mol Med 17: 659&#x2013;667</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202652</ArticleId><ArticleId IdType="pubmed">21783422</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Hwang AW, Restrepo CR, Yuan CX, Trojanowski JQ, Lee VM (2015) An acetylation switch controls TDP&#x2010;43 function and aggregation propensity. Nat Commun 6: 5845</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppede F (2014) The potential of epigenetic therapies in neurodegenerative diseases. Front Genet 5: 220</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4094885</ArticleId><ArticleId IdType="pubmed">25071843</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ (2004) Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 200: 689&#x2013;695</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2212744</ArticleId><ArticleId IdType="pubmed">15337792</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbin MM, Madabhushi R, Pan L, Chen Y, Kim D, Gao J, Ahanonu B, Pao PC, Qiu Y, Zhao Y et&#xa0;al (2013) SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. Nat Neurosci 16: 1008&#x2013;1015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758134</ArticleId><ArticleId IdType="pubmed">23852118</ArticleId></ArticleIdList></Reference><Reference><Citation>Dovey OM, Foster CT, Cowley SM (2010) Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc Natl Acad Sci USA 107: 8242&#x2013;8247</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2889513</ArticleId><ArticleId IdType="pubmed">20404188</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang YS, Tsai KJ, Chang YJ, Kao P, Woods R, Kuo PH, Wu CC, Liao JY, Chou SC, Lin V et&#xa0;al (2014) Full&#x2010;length TDP&#x2010;43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia&#x2010;TDP patients. Nat Commun 5: 4824</Citation><ArticleIdList><ArticleId IdType="pubmed">25215604</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira RC, Popova EY, James J, Briones MR, Zhang SS, Barnstable CJ (2017) Histone deacetylase 1 is essential for rod photoreceptor differentiation by regulating acetylation at histone H3 lysine 9 and histone H4 lysine 12 in the mouse retina. J Biol Chem 292: 2422&#x2013;2440</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5313111</ArticleId><ArticleId IdType="pubmed">28028172</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Sananbenesi F, Mungenast A, Tsai LH (2010) Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol Sci 31: 605&#x2013;617</Citation><ArticleIdList><ArticleId IdType="pubmed">20980063</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong J, Huang M, Wang F, Ma X, Liu H, Tu Y, Xing L, Zhu X, Zheng H, Fang J et&#xa0;al (2017) RBM45 competes with HDAC1 for binding to FUS in response to DNA damage. Nucleic Acids Res 45: 12862&#x2013;12876</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5728411</ArticleId><ArticleId IdType="pubmed">29140459</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff J, Tsai LH (2013) Histone acetylation: molecular mnemonics on the chromatin. Nat Rev Neurosci 14: 97&#x2013;111</Citation><ArticleIdList><ArticleId IdType="pubmed">23324667</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Ayer DE, Schreiber SL (1998) A role for histone deacetylase activity in HDAC1&#x2010;mediated transcriptional repression. Proc Natl Acad Sci USA 95: 3519&#x2013;3524</Citation><ArticleIdList><ArticleId IdType="pmc">PMC19868</ArticleId><ArticleId IdType="pubmed">9520398</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrickson ML, Rao AJ, Demerdash ON, Kalil RE (2011) Expression of nestin by neural cells in the adult rat and human brain. PLoS ONE 6: e18535</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3072400</ArticleId><ArticleId IdType="pubmed">21490921</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, Cairns NJ, Grossman M, McMillan CT, Lee EB, Van Deerlin VM, Lee VM, Trojanowski JQ (2015) Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol 129: 469&#x2013;491</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4369168</ArticleId><ArticleId IdType="pubmed">25549971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ (2002) A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 99: 8921&#x2013;8926</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124399</ArticleId><ArticleId IdType="pubmed">12070353</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao PF, Chen YR, Liu XB, DeCarli C, Seeley WW, Jin LW (2015) Detection of TDP&#x2010;43 oligomers in frontotemporal lobar degeneration&#x2010;TDP. Ann Neurol 78: 211&#x2013;221</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4822421</ArticleId><ArticleId IdType="pubmed">25921485</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Frank CL, Dobbin MM, Tsunemoto RK, Tu W, Peng PL, Guan JS, Lee BH, Moy LY, Giusti P et&#xa0;al (2008) Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 60: 803&#x2013;817</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2912147</ArticleId><ArticleId IdType="pubmed">19081376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, Casaccia P (2010) HDAC1 in axonal degeneration: a matter of subcellular localization. Cell Cycle 9: 3680&#x2013;3684</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995919</ArticleId><ArticleId IdType="pubmed">20930523</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, Shen S, Dietz K, He Y, Howell O, Reynolds R, Casaccia P (2010) HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat Neurosci 13: 180&#x2013;189</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2829989</ArticleId><ArticleId IdType="pubmed">20037577</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T et&#xa0;al (2002) Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 21: 2672&#x2013;2681</Citation><ArticleIdList><ArticleId IdType="pmc">PMC126040</ArticleId><ArticleId IdType="pubmed">12032080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier&#x2010;Tourenne C, Polymenidou M, Cleveland DW (2010) TDP&#x2010;43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19: R46&#x2013;R64</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi G, Gao Y, Liu S, Ye E, Li Y, Jin X, Yang H, Yang Z (2016) Cyclin&#x2010;dependent kinase inhibitor flavopiridol promotes remyelination in a cuprizone induced demyelination model. Cell Cycle 15: 2780&#x2013;2791</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5053583</ArticleId><ArticleId IdType="pubmed">27580304</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller KM, Tjeertes JV, Coates J, Legube G, Polo SE, Britton S, Jackson SP (2010) Human HDAC1 and HDAC2 function in the DNA&#x2010;damage response to promote DNA nonhomologous end&#x2010;joining. Nat Struct Mol Biol 17: 1144&#x2013;1151</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3018776</ArticleId><ArticleId IdType="pubmed">20802485</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Hideshima T, Akiyama M, Chauhan D, Munshi N, Gu X et&#xa0;al (2004) Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications. Proc Natl Acad Sci USA 101: 540&#x2013;545</Citation><ArticleIdList><ArticleId IdType="pmc">PMC327183</ArticleId><ArticleId IdType="pubmed">14695887</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery RL, Hsieh J, Barbosa AC, Richardson JA, Olson EN (2009) Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc Natl Acad Sci USA 106: 7876&#x2013;7881</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2683090</ArticleId><ArticleId IdType="pubmed">19380719</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayan PJ, Lill C, Faull R, Curtis MA, Dragunow M (2015) Increased acetyl and total histone levels in post&#x2010;mortem Alzheimer's disease brain. Neurobiol Dis 74: 281&#x2013;294</Citation><ArticleIdList><ArticleId IdType="pubmed">25484284</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et&#xa0;al (2006) Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari&#x2010;Javan S, Agis&#x2010;Balboa RC, Cota P, Wittnam JL, Gogol&#x2010;Doering A, Opitz L et&#xa0;al (2010) Altered histone acetylation is associated with age&#x2010;dependent memory impairment in mice. Science 328: 753&#x2013;756</Citation><ArticleIdList><ArticleId IdType="pubmed">20448184</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier&#x2010;Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C et&#xa0;al (2011) Long pre&#x2010;mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP&#x2010;43. Nat Neurosci 14: 459&#x2013;468</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S, Bowser R (2003) Alterations in G(1) to S phase cell&#x2010;cycle regulators during amyotrophic lateral sclerosis. Am J Pathol 162: 823&#x2013;835</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868100</ArticleId><ArticleId IdType="pubmed">12598317</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpole S, Watson RJ, te Riele H, Dynlacht BD (2002) E2F mediates cell cycle&#x2010;dependent transcriptional repression in&#xa0;vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev 16: 933&#x2013;947</Citation><ArticleIdList><ArticleId IdType="pmc">PMC152357</ArticleId><ArticleId IdType="pubmed">11959842</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanphui P, Pramanik SK, Chatterjee N, Moorthi P, Banerji B, Biswas SC (2013) Efficacy of cyclin dependent kinase 4 inhibitors as potent neuroprotective agents against insults relevant to Alzheimer's disease. PLoS ONE 8: e78842</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3823981</ArticleId><ArticleId IdType="pubmed">24244372</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Kumar D, Jha NK, Jha SK, Ambasta RK, Kumar P (2017) Re&#x2010;expression of cell cycle markers in aged neurons and muscles: whether cells should divide or die? Biochim Biophys Acta 1863: 324&#x2013;336</Citation><ArticleIdList><ArticleId IdType="pubmed">27639832</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai KJ, Yang CH, Fang YH, Cho KH, Chien WL, Wang WT, Wu TW, Lin CP, Fu WM, Shen CK (2010) Elevated expression of TDP&#x2010;43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD&#x2010;U. J Exp Med 207: 1661&#x2013;1673</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916125</ArticleId><ArticleId IdType="pubmed">20660618</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IF, Wu LS, Shen CK (2008) TDP&#x2010;43: an emerging new player in neurodegenerative diseases. Trends Mol Med 14: 479&#x2013;485</Citation><ArticleIdList><ArticleId IdType="pubmed">18929508</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IF, Guo BS, Liu YC, Wu CC, Yang CH, Tsai KJ, Shen CK (2012) Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA&#x2010;binding protein 43. Proc Natl Acad Sci USA 109: 15024&#x2013;15029</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WY, Pan L, Su SC, Quinn EJ, Sasaki M, Jimenez JC, Mackenzie IR, Huang EJ, Tsai LH (2013) Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat Neurosci 16: 1383&#x2013;1391</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5564396</ArticleId><ArticleId IdType="pubmed">24036913</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner P, Pitt D, Raine CS (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50: 169&#x2013;180</Citation><ArticleIdList><ArticleId IdType="pubmed">11506399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I, Smits V, Ceuterick&#x2010;de Groote C, Van Broeckhoven C, Kumar&#x2010;Singh S (2010) TDP&#x2010;43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 107: 3858&#x2013;3863</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CC, Lien CC, Hou WH, Chiang PM, Tsai KJ (2016) Gain of BDNF function in engrafted neural stem cells promotes the therapeutic potential for Alzheimer's disease. Sci Rep 6: 27358</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4893631</ArticleId><ArticleId IdType="pubmed">27264956</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CC, Wang IF, Chiang PM, Wang LC, Shen CJ, Tsai KJ (2017) G&#x2010;CSF&#x2010;mobilized bone marrow mesenchymal stem cells replenish neural lineages in Alzheimer's disease mice via CXCR4/SDF&#x2010;1 chemotaxis. Mol Neurobiol 54: 6198&#x2013;6212</Citation><ArticleIdList><ArticleId IdType="pubmed">27709493</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Geldmacher DS, Herrup K (2001) DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 21: 2661&#x2013;2668</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762514</ArticleId><ArticleId IdType="pubmed">11306619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zupkovitz G, Grausenburger R, Brunmeir R, Senese S, Tischler J, Jurkin J, Rembold M, Meunier D, Egger G, Lagger S et&#xa0;al (2010) The cyclin&#x2010;dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation. Mol Cell Biol 30: 1171&#x2013;1181</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2820891</ArticleId><ArticleId IdType="pubmed">20028735</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>